These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9578858)

  • 1. Calculating appropriate target cancer detection rates and expected interval cancer rates for the UK NHS Breast Screening Programme. Interval Cancer Working Group.
    Moss S; Blanks R
    J Epidemiol Community Health; 1998 Feb; 52(2):111-5. PubMed ID: 9578858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Results from the NHS breast screening programme 1990-1993.
    Moss SM; Michel M; Patnick J; Johns L; Blanks R; Chamberlain J
    J Med Screen; 1995; 2(4):186-90. PubMed ID: 8719146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer detection rates, and standardised detection ratios for prevalence screening in the New Zealand breast cancer screening programme.
    Richardson A; Graham P; Brown T; Smale P; Cox B
    J Med Screen; 2004; 11(2):65-9. PubMed ID: 15153320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Scottish breast screening programme's experience of monitoring interval cancers.
    Everington D; Gilbert FJ; Tyack C; Warner J
    J Med Screen; 1999; 6(1):21-7. PubMed ID: 10321366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results from the UK NHS Breast Screening Programme 2000-05.
    Bennett RL; Blanks RG; Patnick J; Moss SM
    J Med Screen; 2007; 14(4):200-4. PubMed ID: 18078565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring interval cancers in breast screening programmes: the east Anglian experience. Quality Assurance Management Group of the East Anglian Breast Screening Programme.
    Day N; McCann J; Camilleri-Ferrante C; Britton P; Hurst G; Cush S; Duffy S
    J Med Screen; 1995; 2(4):180-5. PubMed ID: 8719145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study.
    Duffy SW; Dibden A; Michalopoulos D; Offman J; Parmar D; Jenkins J; Collins B; Robson T; Scorfield S; Green K; Hall C; Liao XH; Ryan M; Johnson F; Stevens G; Kearins O; Sellars S; Patnick J
    Lancet Oncol; 2016 Jan; 17(1):109-14. PubMed ID: 26655422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results from the UK NHS breast screening programme 1994-1999.
    Blanks RG; Moss SM; Patnick J
    J Med Screen; 2000; 7(4):195-8. PubMed ID: 11202586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring the performance of breast screening programmes: use of indirect standardisation in evaluating the invasive cancer detection rate.
    Blanks RG; Day NE; Moss SM
    J Med Screen; 1996; 3(2):79-81. PubMed ID: 8849764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What should the detection rates of cancers be in breast screening programmes?
    Duffy SW; Gabe R
    Br J Cancer; 2005 Feb; 92(3):597-600. PubMed ID: 15668711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
    Lynge E
    APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interval cancers in the Dutch breast cancer screening programme.
    Fracheboud J; de Koning HJ; Beemsterboer PM; Boer R; Verbeek AL; Hendriks JH; van Ineveld BM; Broeders MJ; de Bruyn AE; van der Maas PJ
    Br J Cancer; 1999 Nov; 81(5):912-7. PubMed ID: 10555768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region.
    Woodman CB; Threlfall AG; Boggis CR; Prior P
    BMJ; 1995 Jan; 310(6974):224-6. PubMed ID: 7866124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interval cancers in the NHS breast cancer screening programme in England, Wales and Northern Ireland.
    Bennett RL; Sellars SJ; Moss SM
    Br J Cancer; 2011 Feb; 104(4):571-7. PubMed ID: 21285989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National Health Service breast screening programme results for 1991-2.
    Chamberlain J; Moss SM; Kirkpatrick AE; Michell M; Johns L
    BMJ; 1993 Aug; 307(6900):353-6. PubMed ID: 8374416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling the impact of detecting and treating ductal carcinoma in situ in a breast screening programme.
    McCann J; Treasure P; Duffy S
    J Med Screen; 2004; 11(3):117-25. PubMed ID: 15333269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of cancer detection rates achieved by breast cancer screening programmes by number of readers, for one and two view mammography: results from the UK National Health Service breast screening programme.
    Blanks RG; Wallis MG; Moss SM
    J Med Screen; 1998; 5(4):195-201. PubMed ID: 9934650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interval cancer rates in the Irish national breast screening programme.
    O'Brien KM; Dwane F; Kelleher T; Sharp L; Comber H
    J Med Screen; 2015 Sep; 22(3):136-43. PubMed ID: 25917389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of the prevalent round of the breast screening programme in south east Thames, 1988-1993: achievement of quality standards and population impact.
    Garvican L; Littlejohns P
    J Med Screen; 1996; 3(3):123-8. PubMed ID: 8946306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of number of views and mammographic film density on the detection of invasive cancers: results from the NHS Breast Screening Programme.
    Young KC; Wallis MG; Blanks RG; Moss SM
    Br J Radiol; 1997 May; 70(833):482-8. PubMed ID: 9227229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.